Research and analysis

ACRE advice: application for a trial of GM Adenovirus 4 (16/R49/01)

ACRE's advice on an application to investigate the effectiveness of an oral vaccine in inducing an immune response to HIV.



This document is the Advisory Committee on Releases to the Environment (ACRE’s) advice to government in considering a request from Imperial College London (16/R49/01). The application is for a deliberate release of genetically modified virus (the vaccine) based on Adenovirus 4.

ACRE is satisfied that the trial will not have an adverse effect on human health or the environment.

Published 10 March 2017